SES - Delayed Quote SGD

Raffles Medical Group Ltd (BSL.SI)

1.0400
-0.0100
(-0.95%)
At close: 5:04:45 PM GMT+8
Loading Chart for BSL.SI
  • Previous Close 1.0500
  • Open 1.0500
  • Bid 1.0300 x --
  • Ask 1.0400 x --
  • Day's Range 1.0300 - 1.0500
  • 52 Week Range 0.8200 - 1.0500
  • Volume 3,720,000
  • Avg. Volume 3,120,461
  • Market Cap (intraday) 1.925B
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) 34.67
  • EPS (TTM) 0.0300
  • Earnings Date Jul 28, 2025 - Aug 1, 2025
  • Forward Dividend & Yield 0.03 (2.38%)
  • Ex-Dividend Date May 13, 2025
  • 1y Target Est 1.10

Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through four segments: Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services. Its Raffles Hospital, a tertiary care hospital that offers 24-hour acute and critical care, family medicine services, health screening, and a range of multi-disciplinary specialist clinics; appointed wards, day surgery, angiography suites, delivery suites, operating theatres, intensive care unit, and neonatal intensive care unit; and radiology, clinical laboratory, pharmacy, dietetics, rehabilitation, and traditional Chinese medicine, as well as dental services and emergency services. The company also trades in pharmaceutical and nutraceutical products, and diagnostic equipment; and provides management and consultancy services. In addition, it engages in the operation of medical clinics and other general medical services; provides specialized medical services; operation of medical laboratory and imaging center; and provision of health insurance products, as well as investment holding activities in investment properties. The company was founded in 1976 and is based in Singapore. Raffles Medical Group Ltd operates as a subsidiary of Raffles Medical Holdings Pte Ltd.

www.rafflesmedicalgroup.com

2,989

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BSL.SI

View More

Performance Overview: BSL.SI

Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is STI Index (^STI) .

YTD Return

BSL.SI
22.35%
STI Index (^STI)
1.60%

1-Year Return

BSL.SI
2.36%
STI Index (^STI)
17.88%

3-Year Return

BSL.SI
8.85%
STI Index (^STI)
16.90%

5-Year Return

BSL.SI
29.20%
STI Index (^STI)
48.47%

Compare To: BSL.SI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BSL.SI

View More

Valuation Measures

As of 5/8/2025
  • Market Cap

    1.92B

  • Enterprise Value

    1.67B

  • Trailing P/E

    31.14

  • Forward P/E

    28.90

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.57

  • Price/Book (mrq)

    1.83

  • Enterprise Value/Revenue

    2.22

  • Enterprise Value/EBITDA

    12.29

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.27%

  • Return on Assets (ttm)

    3.48%

  • Return on Equity (ttm)

    5.91%

  • Revenue (ttm)

    752.41M

  • Net Income Avi to Common (ttm)

    62.24M

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    343.67M

  • Total Debt/Equity (mrq)

    8.67%

  • Levered Free Cash Flow (ttm)

    57.6M

Research Analysis: BSL.SI

View More

People Also Watch